Maya Sasson

About the Author Maya Sasson

Maya Sasson, originally from San Francisco, California, is a financial writer focusing on U.S. stocks as well as analyst activity. Before diving into the world of financial writing, she earned a B.S. in Mathematics from Tufts University, and began her career as a data analyst for a software company.

Sorrento Provides Manufacturing Support for COVID-19 Treatment; What’s Next?

The battle against COVID-19 is well underway, and now’s the time to send in the big guns. Sorrento Therapeutics (SRNE) is on it, …

Inovio Advances COVID-19 Vaccine to Phase 1 Testing; Analyst Reiterates ‘Buy’

Amid the ongoing public health crisis, Wall Street is eagerly awaiting any piece of good news. Inovio Pharmaceuticals (INO) just came through.

Pluristem Changes the Game with Strong Preliminary COVID-19 Results; Analyst Says ‘Buy’

With the war against COVID-19 waging on, Wall Street focus has locked in on the names at the frontline. Battling a formidable opponent …

Co-Diagnostics’ COVID-19 Test Gets FDA Emergency Use Authorization; Analyst Says ‘Buy’

The clock is ticking to stop COVID-19 dead in its tracks, and diagnostics company Co-Diagnostics (CODX) isn’t wasting any time. For investors thinking …

Billionaire Steven Cohen Picks up These 2 Stocks on the Dip

Stocks roared higher on Monday, but one legendary hedge fund manager isn’t breaking out the champagne just yet. Optimism that COVID-19’s spread may …

3 Healthcare Stocks Fighting the Coronavirus

It’s a new week, and market watchers are bracing themselves for whatever comes their way. Ahead of the opening bell on Monday U.

Will These 3 Coronavirus Stocks Lead the Market to Recovery?

Almost three months have passed since COVID-19 began its spread beyond China’s borders, and the market remains in free fall. Capping off another volatile week, stocks fell on Friday April 3 in response …

J.P. Morgan: 3 Risky Stocks to Sell Now

New month, same volatility. Kicking off the second quarter of 2020, all three of the major U.

Morgan Stanley: 2 Stocks to Buy (and 1 to Stay Away From)

The most recent quarter marked the worst first quarter on record for both the S&P 500 and the Dow Jones. For investors in …

3 Penny Stocks With Triple-Digit Upside Potential

Buckle up, we’re in for a bumpy ride. The number of new coronavirus (COVID-19) cases continues to surge, and as such, the market’s …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts